1. AB0407 Comparative effectiveness of tocilizumab (TCZ) monotherapy with tumor necrosis factor inhibitors (TNFI) in combination with varying doses of methotrexate (MTX) in patients with rheumatoid arthritis. (15th June 2017) Authors: Harrold, LR; Reed, GW; Best, J; Zlotnick, S; Persuitte, G; Kremer, JM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0079 Enbrel® (etanercept) in addition to methotrexate (mtx) in rheumatoid arthritis (ra): long-term observations. (1st June 2001) Authors: Fleischmann, RM; Weinblatt, ME; Kremer, JM; Bankhurst, AD; Bulpitt, KJ; Burge, DJ Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0188 Effectiveness of adalimumab combination therapy with methotrexate and non-methotrexate csdmards: results from the corrona rheumatoid arthritis registry. (15th June 2017) Authors: Pappas, D; Griffith, J; Schlacher, CA; Suboticki, JL; Harrison, RW; Shan, Y; Karki, C; Kremer, JM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0022 TNFI and TOFACITINIB monotherapy and comparative effectiveness in clinical practice: results from corrona registry. (15th June 2017) Authors: Reed, GW; Gerber, RA; Shan, Y; Takiya, L; Dandreo, KJ; Gruben, D; Kremer, JM; Wallenstein, GV Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0104 The impact of disease activity on patient reported cognitive dysfunction ("brain fog") in rheumatoid arthritis. (15th June 2017) Authors: Reed, GW; Harrold, LR; Pala, O; Kremer, JM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0153 Effectiveness of low and high dose methotrexate in combination with adalimumab in a real world setting: results from the corrona rheumatoid arthritis registry. (15th June 2017) Authors: Pappas, D; Griffith, J; Schlacher, CA; Shan, Y; Karki, C; Kremer, JM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0155 Adalimumab in combination with non-methotrexate conventional synthetic disease modifying rheumatic drugs in a clinical trial setting. (15th June 2017) Authors: Keystone, EC; Suboticki, J; Griffith, J; Zhang, Y; Kremer, JM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0192 Combination therapy of leflunomide (lef) and methotrexate (mtx) is effective and well tolerated in rheumatoid arthritis (ra) patients inadequately responding to methotrexate (mtx) alone. (1st June 2001) Authors: Kremer, JM; Genovese, M; Cannon, GW; Caldwell, JR; Cush, JJ; Luggen, ME; Furst, DE; Crawford, B; Bathon, J Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗